Exact Imaging Welcomes Two New U.S. Commercial Team Members

Exact Imaging has expanded its U.S. commercial team as the company continues to build momentum across major health systems.

“We are seeing accelerated demand for our technology in North America and throughout the rest of the world,” Exact Imaging CEO Randy AuCoin stated. “Investing in our sales team is our top priority, as it ensures we have the resources and momentum to support the growing number of physicians and health systems adopting our micro-ultrasound platform.”

The expansion includes the promotion of Tim Heyer to vice president, North American Sales. Heyer is a U.S. Marine Corps veteran with 35 years of experience in medical device sales and service, having helped launch three U.S. Food and Drug Administration (FDA)-cleared devices over the course of his career. He previously served as vice president of Sales and Service at EDAP Technomed, where he built the sales and service organization that supported the Prostatron, a pioneering urology product, ahead of its FDA approval in 1996. He later led a mobile urology service business that expanded from eight states to 42 states before its acquisition by Boston Scientific Corp. in 2007, where he continued to lead the operation.

Joining Heyer on the expanded team is Drew Moore, who is now sales executive for the Northeast region. Moore has more than 20 years of medical sales experience. His deep familiarity with the U.S. healthcare market and established relationships within the urological community will accelerate growth across the Northeast, executives claim.

“My focus has always been on building strong relationships with physicians and understanding their needs for providing the best care for their patients,” Heyer said. “As we grow our presence in the U.S., Exact Imaging is committed to making sure more urologists have access to our proven micro-ultrasound technology.”

Exact Imaging plans to add sales representatives in the Midwest and West Coast regions, and expects to have four to five regional sales professionals on board by the end of the year.

Several U.S. academic and community health centers have recently installed additional systems, reflecting increasing confidence in micro-ultrasound as an alternative or complement to MRI for prostate cancer detection. The company also continues to build clinical evidence supporting its platform, including ongoing research into image-guided biopsy, focal therapy, and active surveillance.

Exact Imaging considers itself the world’s leader in high-resolution micro-ultrasound systems enabling real-time imaging and guided biopsies for prostate cancer. Its ExactVu micro-ultrasound platform and FusionVu micro-US/MRI fusion application have received regulatory approval in the European Union, the United States, and Canada.